Osaic Holdings’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-500
| Closed | -$6.54K | – | 7814 |
|
|
2025
Q4 | $6.54K | Buy |
+500
| New | +$5.97K | ﹤0.01% | 6552 |
|
|
2025
Q2 | – | Sell |
-640
| Closed | -$3.42K | – | 7745 |
|
|
2025
Q1 | $3.42K | Sell |
640
-381
| -37% | -$2.67K | ﹤0.01% | 6372 |
|
|
2024
Q4 | $9.13K | Sell |
1,021
-31,572
| -97% | -$335K | ﹤0.01% | 5858 |
|
|
2024
Q3 | $359K | Buy |
32,593
+136
| +0.4% | +$1.51K | ﹤0.01% | 3173 |
|
|
2024
Q2 | $295K | Buy |
32,457
+194
| +0.6% | +$1.89K | ﹤0.01% | 3234 |
|
|
2024
Q1 | $454K | Buy |
32,263
+31,701
| +5,641% | +$395K | ﹤0.01% | 3019 |
|
|
2023
Q4 | $4.32K | Hold |
562
| – | – | ﹤0.01% | 6226 |
|
|
2023
Q3 | $4.19K | Hold |
562
| – | – | ﹤0.01% | 6347 |
|
|
2023
Q2 | $4.68K | Hold |
562
| – | – | ﹤0.01% | 6349 |
|
|
2023
Q1 | $7.47K | Buy |
+562
| New | +$7.6K | ﹤0.01% | 6143 |
|
|
2021
Q4 | – | Sell |
-93
| Closed | -$1K | – | 7368 |
|
|
2021
Q3 | $1K | Hold |
93
| – | – | ﹤0.01% | 6968 |
|
|
2021
Q2 | $1K | Hold |
93
| – | – | ﹤0.01% | 6815 |
|
|
2021
Q1 | $2K | Buy |
+93
| New | +$1.68K | ﹤0.01% | 6461 |
|
|
2020
Q4 | – | Sell |
-93
| Closed | -$3K | – | 6385 |
|
|
2020
Q3 | $3K | Hold |
93
| – | – | ﹤0.01% | 5701 |
|
|
2020
Q2 | $4K | Sell |
93
-20
| -18% | -$712 | ﹤0.01% | 5540 |
|
|
2020
Q1 | $2K | Buy |
+113
| New | +$3.5K | ﹤0.01% | 5643 |
|
Osaic Holdings's ATXS Position: Q1 2026 in Review
Osaic Holdings sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 500 shares — an estimated $6.54K sold.
Osaic Holdings first reported a position in ATXS in Q1 2020 and held it in 16 quarters. The position peaked at $454K in Q1 2024. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.
- Osaic Holdings reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
- Osaic Holdings sold 500 Astria Therapeutics shares in Q1 2026, an estimated $6.54K.
- Osaic Holdings first reported a position in Astria Therapeutics in Q1 2020 and held it in 16 quarters.
- Osaic Holdings's Astria Therapeutics position peaked at $454K in Q1 2024.
- 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.